"comirnaty"

#9380658

2 January 2023

People walks pass a sign for the Comirnaty mRNA Vaccine by German biotechnology company BioNTech SE. at a Covid-19 vaccination station inside an MTR Station on January 2, 2023 in Hong Kong, China.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#9380652

2 January 2023

A man walks pass a sign for the Sinovac CoronaVac Inactivated Vaccine by China Biotechnology company, Sinovac Biotech Ltd. and a sign for the Comirnaty mRNA Vaccine by German biotechnology company BioNTech SE. at a Covid-19 vaccination station inside an MTR Station on January 2, 2023 in Hong Kong, China.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#9380654

2 January 2023

a sign for the Sinovac CoronaVac Inactivated Vaccine by China Biotechnology company, Sinovac Biotech Ltd. and a sign for the Comirnaty mRNA Vaccine by German biotechnology company BioNTech SE. at a Covid-19 vaccination station inside an MTR Station on January 2, 2023 in Hong Kong, China.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#9380662

2 January 2023

(Left) A sign for the Sinovac CoronaVac Inactivated Vaccine by China Biotechnology company, Sinovac Biotech Ltd., and (Right)a sign for the Comirnaty mRNA Vaccine by German biotechnology company BioNTech SE. inside an MTR Station on January 2, 2023 in Hong Kong, China.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#9380664

2 January 2023

(Left) A sign for the Sinovac CoronaVac Inactivated Vaccine by China Biotechnology company, Sinovac Biotech Ltd., and (Right)a sign for the Comirnaty mRNA Vaccine by German biotechnology company BioNTech SE. inside an MTR Station on January 2, 2023 in Hong Kong, China.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#9380666

2 January 2023

(Left) A sign for the Sinovac CoronaVac Inactivated Vaccine by China Biotechnology company, Sinovac Biotech Ltd., and (Right)a sign for the Comirnaty mRNA Vaccine by German biotechnology company BioNTech SE. inside an MTR Station on January 2, 2023 in Hong Kong, China.

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8669370

15 August 2022

Senior vaccinations against Covid-19 in Warsaw, Poland on January 25, 2021

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8669918

15 August 2022

Senior vaccinations against Covid-19 in Warsaw, Poland on January 25, 2021

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#8669920

15 August 2022

Senior vaccinations against Covid-19 in Warsaw, Poland on January 25, 2021

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#7633372

14 January 2022

Close-up at the syringe and vial of Moderna vaccine with the Moderna inscription. GGD public medical healthcare worker prepares the Moderna Spikevax mRNA Covid-19 vaccines drawing them from the vial glass bottle to individual doses in the syringes at the special area in the mega vaccination center in Eindhoven. The jabs are administered as a booster shot. The third-dose booster is available for all in the Netherlands in addition to the lockdown as the nation battles outbreaks of the new omicron variant coronavirus mutation of the pandemic. Eindhoven, The Netherlands on January 7, 2022

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#7633374

14 January 2022

Female GGD public medical healthcare worker with a facemask prepares the Moderna Spikevax mRNA Covid-19 vaccines drawing them from the vial glass bottle to individual doses in the syringes at the special area in the mega vaccination center in Eindhoven. The jabs are administered as a booster shot. The third-dose booster is available for all in the Netherlands in addition to the lockdown as the nation battles outbreaks of the new omicron variant coronavirus mutation of the pandemic. Eindhoven, The Netherlands on January 7, 2022

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#7633376

14 January 2022

Close-up at the syringe, vial and hands of a woman preparing the booster shot. GGD public medical healthcare worker prepares the Moderna Spikevax mRNA Covid-19 vaccines drawing them from the vial glass bottle to individual doses in the syringes at the special area in the mega vaccination center in Eindhoven. The jabs are administered as a booster shot. The third-dose booster is available for all in the Netherlands in addition to the lockdown as the nation battles outbreaks of the new omicron variant coronavirus mutation of the pandemic. Eindhoven, The Netherlands on January 7, 2022

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#7633378

14 January 2022

Close-up at a vial with a needle and the booster inscription. GGD public medical healthcare worker prepares the Moderna Spikevax mRNA Covid-19 vaccines drawing them from the vial glass bottle to individual doses in the syringes at the special area in the mega vaccination center in Eindhoven. The jabs are administered as a booster shot. The third-dose booster is available for all in the Netherlands in addition to the lockdown as the nation battles outbreaks of the new omicron variant coronavirus mutation of the pandemic. Eindhoven, The Netherlands on January 7, 2022

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#7633380

14 January 2022

GGD public medical healthcare worker prepares the Moderna Spikevax mRNA Covid-19 vaccines drawing them from the vial glass bottle to individual doses in the syringes at the special area in the mega vaccination center in Eindhoven. The jabs are administered as a booster shot. The third-dose booster is available for all in the Netherlands in addition to the lockdown as the nation battles outbreaks of the new omicron variant coronavirus mutation of the pandemic. Eindhoven, The Netherlands on January 7, 2022

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#7633382

14 January 2022

Close-up at the syringe, vial and hands of a woman preparing the booster shot. GGD public medical healthcare worker prepares the Moderna Spikevax mRNA Covid-19 vaccines drawing them from the vial glass bottle to individual doses in the syringes at the special area in the mega vaccination center in Eindhoven. The jabs are administered as a booster shot. The third-dose booster is available for all in the Netherlands in addition to the lockdown as the nation battles outbreaks of the new omicron variant coronavirus mutation of the pandemic. Eindhoven, The Netherlands on January 7, 2022

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.

#7633384

14 January 2022

Close-up at the syringe, vial and hands of a woman preparing the booster shot. GGD public medical healthcare worker prepares the Moderna Spikevax mRNA Covid-19 vaccines drawing them from the vial glass bottle to individual doses in the syringes at the special area in the mega vaccination center in Eindhoven. The jabs are administered as a booster shot. The third-dose booster is available for all in the Netherlands in addition to the lockdown as the nation battles outbreaks of the new omicron variant coronavirus mutation of the pandemic. Eindhoven, The Netherlands on January 7, 2022

Restricted to Editorial Use Only.
Commercial use is not permitted without prior authorization.
Please contact us for more information.